Cardiorobotics Inc.
This article was originally published in Start Up
Executive Summary
Cardiorobotics has developed a highly articulated robotic catheter with 32 degrees of freedom and multiple internal lumens through which off-the-shelf surgical tools and catheters can be delivered. The company's founders believe that the Cardiorobotics platform is very suitable for NOTES procedures, but in the short term, while the NOTES market develops, Cardiorobotics is initially focused on a single-port approach. It diverges from its peers in the NOTES and single-port spaces, many of which are focusing on minimally invasive gallbladder removal and other gastroenterology procedures, by addressing minimally invasive cardiac surgery, specifically, applications in electrophysiology, where there is plenty of business to feed a small company.
You may also be interested in...
TransEnterix: Managing Revolutions in Surgery
Minimally invasive surgery, performed through a number of ports to create access and enable visualization, manipulation, and dissection, promised to revolutionize surgical techniques two decades ago, but ultimately fell short of changing the way surgeons perform the majority of surgical cases. Now, the next generation in minimally invasive surgery sees single-port surgeries and natural orifice transluminal endoscopic surgeries (NOTES) gaining momentum. TransEnterix aims to operate in both cases, with a novel approach that not only allows surgeons greater dexterity in performing complex procedures, but also enables them to do surgical cases through a single access port, using the body's umbilicus
Start-Up Previews (01/08)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups are "NOTES Companies Sing an Upbeat Tune," and "Solid Support for Flu Vaccine Development." Plus these Start-Ups Across Health Care: Carigent Therapeutics, Cizzle Biotechnology, Genesis Medical Interventional, and ValveXchange.
NOTES Companies Sing an Upbeat Tune
There was an almost dot-com-like euphoria about NOTES at 2007's annual meetings of endoscopists and surgeons. NOTES (natural orifice translumenal endoscopic surgery) is being described as a revolution in minimally invasive surgery, incisionless surgery, or at the very least, a major advance over laparoscopy. It represents a billion-dollar category not yet dominated by the companies that gained preeminence in the $4 billion worldwide laparoscopy market. But most companies in the area agree that the NOTES revolution isn't going to happen overnight. The challenge for today is to create products and technologies for procedures that can happen in high volume in the near term, while waiting for more advanced NOTES procedures to come about.